Time Restricted Eating in Patients With Microalbuminuria
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity of California, San Diego
About this trial
This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.
Eligibility criteria
Qualifiers
Age: 18-75 years old
Participants with T2DM with A1c between 6.5 and 9.0 % and on stable doses of medications who are weight-bearing and self-ambulatory.
uACR ( urine albumin creatinine ratio) results ≥ 30 - 300 mg.
Willingness to use smartphone for research procedures (Apple iOS or Android OS)
Disqualifiers
Participants with Type1DM and T2DM who are taking insulin, sulfonylureas, or have an HbA1c > 9 %.
Estimated Glomerular Filtration Rate (EGFR) < 45
Systolic BP greater than 160 mmHg and/or Diastolic BP greater than 110 mmHg (with or without treatment/medication)
LDL cholesterol greater than 200 mg/dL
Trial design
Treatments tested in this trial
- Time Restricted Eating
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
University of California, San Diego
Lead sponsor
Salk Institute for Biological Studies
Collaborator
Source ClinicalTrials.gov